Updates

November 24, 2020November 24, 2020
Wolters Launches Alexa Emmi Care Plan to Enable Close Patient-Clinician Contact

A new Alexa healthcare skill, called the Emmi Care Plan, provides a voice service that allows patients to easily remain in contact with their ... Read more
November 19, 2020November 19, 2020
Vaping Linked to Higher Respiratory Disease Risk in Large US Study

Use of electronic cigarettes (e-cigarettes) is associated with an increased risk of respiratory diseases, including chronic obstructive pulmonary disease (COPD), among young adults, irrespective ... Read more
November 17, 2020November 17, 2020
Trial Testing RejuvenAir as Chronic Bronchitis Treatment Still Enrolling in Europe

Enrollment in a clinical trial evaluating the mechanism of action of RejuvenAir Metered Cryospray, CSA Medical’s investigational approach for the treatment of chronic bronchitis, ... Read more
November 12, 2020November 12, 2020
New Therapeutic Target for COPD Identified in Study

Inhibiting a protein called lymphotoxin beta receptor (LTβR) could be an effective therapeutic strategy for chronic obstructive pulmonary disease (COPD), new research suggests. The ... Read more
November 10, 2020November 10, 2020
Philips Launches Novel Non-invasive Ventilator to Monitor COPD Patients Remotely

Royal Philips has launched a non-invasive ventilator, BiPAP A40 EFL, to remotely monitor patients with chronic obstructive pulmonary disease (COPD) and help them to ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

June 20, 2017June 20, 2017

Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients

News

The effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD) are the target of a new clinical trial that stems from a partnership between medical cannabis products company Tilray and the Research Institute of the McGill University ... Read more

Updates

Wolters Launches Alexa Emmi Care Plan to Enable Close Patient-Clinician Contact

Vaping Linked to Higher Respiratory Disease Risk in Large US Study

Trial Testing RejuvenAir as Chronic Bronchitis Treatment Still Enrolling in Europe

New Therapeutic Target for COPD Identified in Study

Philips Launches Novel Non-invasive Ventilator to Monitor COPD Patients Remotely

Study Examines Success of Noninvasive Ventilation in COPD After Acute Exacerbation

Health Care Service Corporation Now Covering Zephyr Valve in US

FDA Gives Clearance to PulmoScan Device for At-home Lung Function Monitoring

Training in Use of Inhaler Devices Seen to Help Older Patients

RejuvenAir System Tested in 1st Trial Participant With COPD and Chronic Bronchitis

European CHMP Gives Positive Opinion to COPD Therapy Trixeo Aerosphere

Subscribe to our mailing list

Prenatal Smoke Exposure May Increase Baby’s Later COPD Risk, Mouse Study Says

No Link Between Face Masks and CO2 Poisoning, Even in People With COPD, Study Finds

Oral Cannabinoids Linked to Higher Mortality Risk in Older COPD Patients, Study Finds

ATS and 4DMedical Offering Grants for Research in COPD, Other Lung Diseases

COPD360Net Seeks to Boost Innovative Digital Health, Therapeutics

Two Phase 3 Trials of Ensifentrine in Safely Treating COPD to Open

COPD More Prevalent Than Estimated, With Mortality Linked to Aspergillosis, Review Finds

Agreement Reached for Hemp Facility to Support Potential COPD Therapy RespRx

Verona’s Ensifentrine Found to Ease Breathlessness, Improve Quality of Life

SNG001 Can Safely Improve Lung Function in COPD Patients With Viral Infections, Interim Data Show

AstraZeneca’s New Data Shows Breztri Aerosphere Better for All Seasons

Low-dose Morphine Improves Health in COPD Patients With Shortness of Breath, Phase 4 Trial Suggests

COPD Study: Fortified Whey Protein Beverage Increases Muscle Strength

Blood Test for IL-32 May Diagnose COPD, Measure Severity, Study Says

New Potential Therapeutic Target – FFA4 Protein – Discovered for COPD

Phase 2 Trial Starts Testing Multiple Doses of Ensifentrine in Inhaler Formulation

University Given $3.9M to Advance Potential COPD Therapy to Clinical Testing

PR1P Peptide Reduces Lung Cell Death, Tissue Damage in Emphysema, Preclinical Study Shows

Healthy Diet Significantly Lowers COPD Risk, Review Study Finds

Free Online ‘Bootcamp’ Aims to Help Those With Lingering COVID-19 Effects

FDA Approves Breztri Aerosphere as COPD Maintenance Treatment

COPD Patients Using Metformin Should Be Aware of Added Risks, Study Shows

Younger Patients Feel Heavier Burden, Greater Impact of COPD, Global Survey Reveals

ProAir Digihaler for COPD and Asthma Now Available in US

COPD Seen as Potential Risk Factor for Lung and Other Cancers

Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients